NCT07421167 · Interventional trial
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Overall registry status Recruiting
Phase 2
Conditions Primary Evans Syndrome (ES), Primary Immune Thrombocytopenia (ITP)
Delaware Valley sites
- Hospital of the University of Pennsylvania Health System · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory